37 results
Page 2 of 2
8-K
EX-10.8
ur347d8qh3xpx
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.6
rllezwe75ti9t w96lod
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.7
vi1l rep4vj4
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.5
lro zxskjn
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
8-K
EX-10.4
7bvje7odb
1 Jul 21
Unaudited pro forma condensed combined financial statements
12:00am
424B3
ynle6f3mkdyz7xyw7
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.16
x64stugm
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
eui1fkttewo0 j1vbf2
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
4enrsetq2ck
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.6
4nvz6qae
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.16
pba y4qbzwhh
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
qbhl9o44p0ja17tf66c
18 Mar 21
Financial Statements and Exhibits
9:08am
8-K
EX-1.1
5sqh718l9uxy5g4zgnb
10 Jul 20
Therapeutics Acquisition Corp., Sponsored by RA Capital Management, L.P., Announces Pricing of Upsized $118 Million Initial Public Offering
5:17pm
S-1
EX-1.1
0ap fqj4aimsfjwtr
15 Jun 20
IPO registration
5:28pm